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We examined the potential sources of error in automated cation-exchange chromatographic quantitation of plasma taurine, both in sample preparation and in the analysis. Principal sources of error include: use of serum instead of plasma, which produces gross overestimates; use of tripotassium ethylenediaminetetraacetate (EDTA) as anticoagulant in systems involving ninhydrin detection (a ninhydrin-positive contaminant of EDTA emerges coincident with taurine); contamination with platelets; and placing volumes exceeding 20 tL on the cartridge used in the Technicon TSM Amino Acid Analyzer. We arrived at a simple technique in which we use EDTA as anticoagulant, micropore filtration to produce platelet-free plasma, and o-phthalaldehyde as the detection reagent for the sensitivity required to measure accurately the low concentration of taurine in plasma.
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Although taurine is one of the most abundant and ubiquitous free amino acids in human tissues (1) , until recently its only well-documented metabolic function has been its conjugation to form taurocholic acid. During the past few years, studies of its neuropharmacologic properties (2) have indicated a potentially more significant role in neurotransmission. In spite of uncertainty as to whether taurine is a neuromodulator or inhibitory neurotransmitter (3, 4) , the consensus is that taurine is a neuroeffector in both the central and peripheral nervous systems (2) was analyzed every fifth sample and the unknowns were quantified by using the average peak height of standards bracketing the unknown. Both detection systems described give linear signals and, owing to the "spike-like" nature of the taurine peak, we find that measurement of peak height provides a reliable estimate of the concentration of taurine in samples.
Materials and Methods
Subjects
Results
The sampling method used with the TSM can lead to seri- (Table 1) show that sample volumes exceeding 20 .iL showed a significant decrease in taurine peak height. The peak heights for the 10-and 20-liL samples did not differ significantly. Not surprisingly, we observed the same effect of applied volume on results for taurine in urine and plasma samples. Clearly, use of sample volumes of 50 .tL or more can lead to significant taurine loss from the cartridge, and use of volumes exceeding 20 tL will probably result in losses that are directly proportional to the volume applied to the cartridge in the TSM system. Presumably, some early-emerging acidic and neutral amino acids are so loosely bound to the cartridge resin that they are eluted by water or the acidic species and are lost when larger volumes are aspirated into the cartridge resin. This problem would not arise with instruments in which fluid to be assayed is placed directly onto the column.
The foregoing 20-zL restriction on sample volume renders impossible the accurate quantitation of the low concentrations of taurine in plasma with ninhydrin as the detection reagent. With use of o-phthalaldehyde conjugation and fluorometric detection, sensitivity was increased almost 100-fold. Analysis of 20 samples of the same taurine standard demonstrated acceptable reproducibility (CV = 4.5%). Duplicate analysis of 20 plasma samples yielded a mean difference of 4.6% (SEM 0.7%). As little as 100 pmol of taurine can be accurately quantified.
The largest potential source of error in the quantitation of plasma taurine is thought to be inadequate removal of platelets (which are rich in taurine) from samples (12) . The method used by most investigators to remove platelets is high-speed centrifugation.
We obtained the same result by using a Millex filter (O.45-lim pore size). Plasma samples thus filtered, examined microscopically, were found to be free of platelets. It is, of course, possible that filtration might have ruptured platelets or induced taurine release through (e.g.) surface effects. To test for these possibilities, we first centrifuged plasma samples from 10 individuals at 650 X g; then aliquots of the supernates were either filtered or centrifuged at 1000 or at 10 000 x g. Taurine analyses of these plasma aliquots bed to means of 42.9 (SEM 2.1), 41.1 (SEM 1.9), and 39.7 (SEM 2.0) mol/L for those centrifuged at 1000 X g, 10 000 X g, and filtered, respectively. Although values for serum taurine significantly exceed those for plasma (15) , no one has compared the common anticoagulants for their potential effects on results of plasma taurine assays. Using aliquots of blood from five subjects, we treated specimens with EDTA, sodium citrate, heparin, or no anticoagulant (serum). Platelets were removed by filtration, as verified by microscopic inspection. The respective mean taurine values for the various treatments were 39.5 (SD 5.4), 37.5 (SD 5.9), 39.9 (SD 5.3), and 85.6 (SD 18.1) mol/L for those anticoagulated with EDTA, sodium citrate, and heparin, and for serum. Note that the variation in sera was disproportionately and significantly higher than that in any plasma aliquot. Two-way analysis of variance revealed a significant difference Heparin causes platelets to aggregate, and this aggregation results in some release of intracellular constituents of platelets (13) . In earlier studies in which heparin was used and the samples were centrifuged at speeds sufficient to remove most platelets, the reported values were high by comparison with our data. Microscopically, platelet aggregation could be seen in all heparinized aliquots before filtration, but not in those treated with sodium citrate or EDTA. However, the amount of taurine released by aggregation must be small, as evidenced by our data above. From these date we conclude that taurine release by platelet aggregation is small relative to intra-indi-vidual variation and experimental error. Using EDTA or sodium citrate as anticoagulant, we found the mean for plasma taurine to be 45.0 (SEM 2.0) zmol/L among our 44 control subjects. The range was 25-93 imol/L. A comparison of mean plasma taurine concentrations in the stone-disease patients with that of normal subjects revealed no significant difference (t = 1.03, 42 d/f, p > 0.3).
Discussion
Our adaptation of the TSM amino acid analyzer to fluorometric analysis was prompted by a previous report in which the Beckman amino acid analyzer was so used (16) . f-Amino acids react well with o-phthalaldehyde to give a good fluorometric yield (17) Recalculating data from their Table I , we found that the reported value should have been 29.4 (SD 3.4) nmol of taurine per 100 000 platelets, a value that still is exceedingly high and might reflect error from a variety of sources, or subject differences.
In papers reporting inaccurately high values for plasma taurine, the cause almost invariably appears to be contamination with platelet taurine. To our knowledge, there are only four reports in the literature that do not differ significantly from our control values. Three of these papers were based on data from five or fewer individuals (1, 19, 21) . Barbeau et al. (22) reported plasma taurine values for 37 individuals used as controls in their study of amino acids in Friedreich's ataxia. Their mean (44, SD 29 tmol/L) for control plasma taurine is essentially the same as ours (45, SD 13 lzmol/L) but their variation around the mean significantly exceeded ours (F = 4.55; 36, 43 d/f, p <0.01). We cannot explain this fact.
We conclude that plasma taurine is most conveniently and accurately measured by using EDTA as the anticoagulant, followed by low-speed centrifugation and micropore filtration to yield platelet-free plasma. Use of o-phthalaldehyde for detection is necessary for accurate quantitation of the low concentrations of several amino acids in plasma, including taurine, and should also prove very useful in measuring taurine in tissue.
